| Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis N Ruperto, HI Brunner, P Quartier, T Constantin, N Wulffraat, G Horneff, ... New England Journal of Medicine 367 (25), 2396-2406, 2012 | 792 | 2012 |
| A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process R Harwood, B Allin, CE Jones, E Whittaker, P Ramnarayan, AV Ramanan, ... The Lancet Child & Adolescent Health 5 (2), 133-141, 2021 | 366 | 2021 |
| The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)—clinical characteristics of children recruited within the first 5 yr LJ McCann, AD Juggins, SM Maillard, LR Wedderburn, JE Davidson, ... Rheumatology 45 (10), 1255-1260, 2006 | 313 | 2006 |
| Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations A Rajab, V Straub, LJ McCann, D Seelow, R Varon, R Barresi, A Schulze, ... PLoS genetics 6 (3), e1000874, 2010 | 261 | 2010 |
| Consensus-based recommendations for the management of juvenile dermatomyositis FB Enders, B Bader-Meunier, E Baildam, T Constantin, P Dolezalova, ... Annals of the rheumatic diseases 76 (2), 329-340, 2017 | 258 | 2017 |
| European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis—the SHARE initiative S Ozen, SD Marks, P Brogan, N Groot, N de Graeff, T Avcin, ... Rheumatology 58 (9), 1607-1616, 2019 | 244 | 2019 |
| The EuroMyositis registry: an international collaborative tool to facilitate myositis research JB Lilleker, J Vencovsky, G Wang, LR Wedderburn, LP Diederichsen, ... Annals of the rheumatic diseases 77 (1), 30-39, 2018 | 243 | 2018 |
| Disease activity, severity, and damage in the UK juvenile‐onset systemic lupus erythematosus cohort L Watson, V Leone, C Pilkington, K Tullus, S Rangaraj, JE McDonagh, ... Arthritis & Rheumatism 64 (7), 2356-2365, 2012 | 235 | 2012 |
| Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis P Riley, LJ McCann, SM Maillard, P Woo, KJ Murray, CA Pilkington Rheumatology 47 (6), 877-880, 2008 | 203 | 2008 |
| European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative N Groot, N De Graeff, T Avcin, B Bader-Meunier, P Brogan, P Dolezalova, ... Annals of the rheumatic diseases 76 (11), 1788-1796, 2017 | 191 | 2017 |
| Survey of paediatric complementary and alternative medicine use in health and chronic illness LJ McCann, SJ Newell Archives of disease in childhood 91 (2), 173-174, 2006 | 172 | 2006 |
| European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease–the SHARE initiative N de Graeff, N Groot, S Ozen, D Eleftheriou, T Avcin, B Bader-Meunier, ... Rheumatology 58 (4), 672-682, 2019 | 170 | 2019 |
| The detection of subclinical synovitis by ultrasound in oligoarticular juvenile idiopathic arthritis: a pilot study KE Haslam, LJ McCann, S Wyatt, RJ Wakefield Rheumatology 49 (1), 123-127, 2010 | 154 | 2010 |
| European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative N Groot, N De Graeff, SD Marks, P Brogan, T Avcin, B Bader-Meunier, ... Annals of the rheumatic diseases 76 (12), 1965-1973, 2017 | 139 | 2017 |
| HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis–scleroderma overlap LR Wedderburn, NJ McHugh, H Chinoy, RG Cooper, F Salway, ... Rheumatology 46 (12), 1786-1791, 2007 | 127 | 2007 |
| European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides–the SHARE initiative N de Graeff, N Groot, P Brogan, S Ozen, T Avcin, B Bader-Meunier, ... Rheumatology 58 (4), 656-671, 2019 | 109 | 2019 |
| Rate and clinical presentation of macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with canakinumab AA Grom, NT Ilowite, V Pascual, HI Brunner, A Martini, D Lovell, ... Arthritis & Rheumatology 68 (1), 218-228, 2016 | 106 | 2016 |
| European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative N Groot, N De Graeff, T Avcin, B Bader-Meunier, P Dolezalova, ... Annals of the rheumatic diseases 76 (10), 1637-1641, 2017 | 92 | 2017 |
| A randomized comparative trial of generalized vs targeted physiotherapy in the management of childhood hypermobility S Kemp, I Roberts, C Gamble, S Wilkinson, JE Davidson, EM Baildam, ... Rheumatology 49 (2), 315-325, 2010 | 91 | 2010 |
| Presentation, treatment response and short-term outcomes in paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS) S Felsenstein, E Willis, H Lythgoe, L McCann, A Cleary, K Mahmood, ... Journal of clinical medicine 9 (10), 3293, 2020 | 71 | 2020 |
